Domestic biosimilar market will exceed USD 100 million by 2019

Published: 2016-01-05 15:34:01

Updated: 2016-01-05 15:34:01

The domestic biosimilar market is expected to exceed USD 100 million by 2019.

The Biotech Policy Research Center expected the Korea biosimilar market will grow in the 7.8% CAGR from USD 70 million in 2012 to USD 120 million, according to its recent ‘BioINwatch(BioIN+Issue+Watch), 15-102’ report.

According to the center, Samsung Bioepis acquired approvals for Brensis(SB4), a biosimilar of the ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.